WO2006063596A8 - Composition renfermant des polypeptides pancreatiques pour le traitement de troubles gastrointestinaux - Google Patents
Composition renfermant des polypeptides pancreatiques pour le traitement de troubles gastrointestinauxInfo
- Publication number
- WO2006063596A8 WO2006063596A8 PCT/DK2005/000796 DK2005000796W WO2006063596A8 WO 2006063596 A8 WO2006063596 A8 WO 2006063596A8 DK 2005000796 W DK2005000796 W DK 2005000796W WO 2006063596 A8 WO2006063596 A8 WO 2006063596A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- gastrointestinal disorders
- composition
- functional
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05818753A EP1827481A2 (fr) | 2004-12-15 | 2005-12-15 | Composition renfermant des polypeptides pancreatiques pour le traitement de troubles gastrointestinaux |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200401939 | 2004-12-15 | ||
DKPA200401939 | 2004-12-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006063596A2 WO2006063596A2 (fr) | 2006-06-22 |
WO2006063596A3 WO2006063596A3 (fr) | 2006-08-24 |
WO2006063596A8 true WO2006063596A8 (fr) | 2007-07-26 |
Family
ID=36539265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2005/000796 WO2006063596A2 (fr) | 2004-12-15 | 2005-12-15 | Composition renfermant des polypeptides pancreatiques pour le traitement de troubles gastrointestinaux |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1827481A2 (fr) |
WO (1) | WO2006063596A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100075439A (ko) * | 2007-09-11 | 2010-07-02 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 감마 1 msh 단독 또는 펜타가스트린과의 배합물 |
RU2010113994A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение панкреатического полипептида человека в качестве терапевтического средства |
WO2009033817A2 (fr) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Utilisation d'un peptide en tant qu'agent thérapeutique |
GB0817067D0 (en) * | 2008-09-18 | 2008-10-22 | 7Tm Pharma As | Intestinal treatment |
US8808734B2 (en) | 2011-07-11 | 2014-08-19 | Full Spectrum Laboratories Limited | Cannabinoid formulations |
-
2005
- 2005-12-15 WO PCT/DK2005/000796 patent/WO2006063596A2/fr active Application Filing
- 2005-12-15 EP EP05818753A patent/EP1827481A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2006063596A3 (fr) | 2006-08-24 |
EP1827481A2 (fr) | 2007-09-05 |
WO2006063596A2 (fr) | 2006-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006096434A3 (fr) | Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete | |
WO2006086562A3 (fr) | Derives de phenylazetidinone | |
WO2005105780A3 (fr) | Compositions utiles en tant qu'inhibiteurs de la rock et d'autres proteines kinases | |
WO2006002361A3 (fr) | 2-methylpropanamides et leur utilisation comme produits pharmaceutiques | |
WO2006070325A3 (fr) | Derives de 2,3,4,9-tetrahydro-1h-carbazole utilises en tant qu'antagonistes des recepteurs de crth2 | |
WO2006035237A3 (fr) | Procedes et compositions lies a la maladie d'alzheimer | |
GEP20125565B (en) | Lactam compounds and their pharmaceutical use | |
WO2006041773A3 (fr) | Composes a base de lactame utiles en tant qu'inhibiteurs de la proteine kinase | |
WO2006116148A3 (fr) | Traitement de l'abus de substances toxiques | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
WO2008076392A3 (fr) | Composés utilisables en tant qu'inhibiteurs de protéines kinases | |
WO2007020213A3 (fr) | Derives de thiazolylpiperidines | |
WO2007044085A3 (fr) | Composes heteroaryle et leurs utilisations en tant qu'agents therapeutiques | |
WO2006044362A3 (fr) | Antagonistes du recepteur 1 de n-sulfonylpiperidine cannabinoide | |
WO2007120252A3 (fr) | Récepteur soluble humain du facteur m-csf et utilisations de celui-ci | |
WO2006057945A3 (fr) | Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
WO2006078576A3 (fr) | Inhibiteurs de la $g(b)-secretase d'aminomethyle dans le traitement de la maladie d'alzheimer | |
WO2007067519A3 (fr) | Utilisation de neurotransmetteurs et de neuropeptides pour le traitement de maladies de secheresse oculaire et de conditions associees | |
WO2006077024A3 (fr) | Derives de 5-aminoindole | |
WO2007143523A3 (fr) | Sulfonamides tricycliques condensés inhibiteurs de gamma-secrétase | |
WO2006055434A3 (fr) | Inhibiteurs de la beta-secretase formes d'amines tertiaires macrocycliques pour le traitement de la maladie d'alzheimer | |
WO2008006795A3 (fr) | Composés d'indole | |
WO2007058862A3 (fr) | Composes d’imidazolidinone utiles en tant qu’inhibiteurs de la beta-secretase lors du traitement de la maladie d’alzheimer | |
WO2009109654A3 (fr) | Nouveaux dérivés de 1-benzyl-3-hydroxyméthylindazole et leur utilisation dans le traitement des maladies basées sur l’expression de mcp-1 et cx3cr1 | |
WO2005082413A3 (fr) | Combinaison de ciclesonide et de glycopyrronium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005818753 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005818753 Country of ref document: EP |